Switch to:
More From Other Websites
Great Stocks With Rising Dividends Jul 23 2016
2:30 am Amgen and UCB submit Biologics License Application to the FDA for Romosozumab Jul 23 2016
Fourth Straight Week Of Gains; Buckle Up For Earnings Jul 22 2016
Amgen Announces 2016 Third Quarter Dividend Jul 22 2016
Amgen Announces Webcast Of 2016 Second Quarter Financial Results Jul 22 2016
Pharma Industry Outlook: Fundamentals Remain Strong Jul 22 2016
Amgen Announces Webcast Of 2016 Second Quarter Financial Results Jul 22 2016
Amgen Announces 2016 Third Quarter Dividend Jul 22 2016
Amgen 2Q Earnings: Here's What To Expect Jul 22 2016
Amgen And UCB Submit Biologics License Application For Romosozumab To The FDA Jul 22 2016
Amgen And UCB Submit Biologics License Application For Romosozumab To The FDA Jul 22 2016
Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin Jul 21 2016
Amgen (AMGN) Stock Rises on 'Non-Inferior' Late-Stage Trial Results Jul 21 2016
Amgen, Allergan biosimilar found as effective as Roche cancer drug Jul 21 2016
Biogen: CEO Departing; Is This Drug Maker In Play? Jul 21 2016
The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen Jul 21 2016
Amgen And Allergan Announce Top-Line Results From Phase 3 Study Evaluating ABP 980 Compared With... Jul 21 2016
Amgen Announces Settlement Of Securities Litigation Jul 20 2016
Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug Jul 20 2016
Amgen’s Kyprolis with Ligand Pharmaceuticals’s Captisol Technology Jul 20 2016
Biotech: As Cheap as They Come Jul 20 2016
These new drugs might never get a chance to save the U.S. $250 billion Jul 20 2016
Novartis Set To Become Biosimilar Pioneer By 2020 Jul 19 2016
U.S. FDA knocks back Novartis copy of Amgen's drug Neulasta Jul 19 2016
Valeant psoriasis drug's suicide risk hard to assess -FDA Staff Jul 15 2016
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan Jul 13 2016
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan Jul 13 2016
Amgen and Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan Jul 13 2016
European Commission Approves Extended Indication For Amgen's Kyprolis® (Carfilzomib) For The... Jul 13 2016
Lower-cost biotech drug gets thumbs up from FDA panel Jul 12 2016
Amgen To Discuss Data Supporting Biologics License Application For ABP 501, A Biosimilar Candidate... Jul 12 2016
FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor Jul 11 2016
European Commission Approves Extended Indication For Amgen's Kyprolis® (Carfilzomib) For The... Jul 04 2016
Takeda Revises Collaboration Agreement with Amgen, Returning the Development and Commercialization... Jun 24 2016
Amgen Sponsors [email protected] Incubator For Life Science Startups Jun 22 2016
Amgen Appoints Esteban Santos Executive Vice President, Operations Jun 17 2016
Amgen Announces FDA Advisory Committee Meeting To Review ABP 501, A Biosimilar Candidate To... Jun 13 2016
Amgen Announces Expiration And Final Results Of Senior Notes Exchange Offers Jun 10 2016
BLINCYTO® (Blinatumomab) Improved Overall Survival In Patients With B-Cell Precursor Acute... Jun 10 2016
Amgen Korea Celebrates New Office Opening Jun 09 2016
Amgen Korea Celebrates New Office Opening Jun 09 2016
Amgen Announces Erenumab (AMG 334) Significantly Reduces Patients' Monthly Migraine Days In Phase 2... Jun 08 2016
Amgen Announces Launch Of KYPROLIS® (carfilzomib) CENTRAL, An Online News Resource Demonstrating... Jun 03 2016
Analysis - Pfizer's Anacor deal showcases new wave of eczema therapies May 17 2016
Exclusive - Medivation succumbs to pressure to explore sale: sources May 09 2016
Sanofi, Amgen cholesterol drugs win UK backing after price cuts May 05 2016
US stocks hit by health care woes but avoid bigger losses Apr 29 2016
Amgen posts 1Q sales, profit jumps, raises profit forecasts Apr 28 2016
Amgen beats Street 1Q forecasts Apr 28 2016
Breakthrough cholesterol drugs fizzle amid price pushback Apr 20 2016
Sean Parker sets up $250 million cancer immunotherapy collaboration Apr 12 2016
FDA approves 1st cheaper version of J&J's top drug Remicade Apr 05 2016
Factbox - Price hikes shore up revenue for top-selling U.S. drugs Apr 04 2016
Exclusive - Makers took big price increases on widely used U.S. drugs Apr 04 2016
US stocks jump after solid March jobs report Apr 01 2016
Regeneron loses patent dispute over key cholesterol drug Mar 16 2016
UK cost agency rejects Amgen's virus-based cancer drug Mar 16 2016
Study: $3B will be wasted on unused portion of cancer drugs Mar 01 2016
UK cost agency rebuffs Sanofi cholesterol drug but backs Amgen's Feb 08 2016
UK cost agency rebuffs Sanofi cholesterol drug but backs Amgen's Feb 08 2016
Amgen fourth quarter profit tops Street; raises 2016 forecast Jan 28 2016
Amgen fourth quarter profit tops Street; raises 2016 forecast Jan 28 2016
Amgen trounces Street views with 39 pct. jump in 4Q profit Jan 28 2016
Amgen beats Street 4Q forecasts Jan 28 2016
Amgen reacquires rights to three drugs from Glaxo in 48 countries Dec 14 2015
Amgen reacquires rights to three drugs from Glaxo in 48 countries Dec 14 2015
Amgen reacquires rights to three drugs from Glaxo in 48 countries Dec 14 2015
Amgen reacquires rights to three drugs from Glaxo in 48 countries Dec 14 2015
UK cost watchdog turns down Amgen's new cholesterol drug Nov 18 2015
UK cost watchdog turns down Amgen's new cholesterol drug Nov 18 2015
Intas Pharma expects U.S. approval for Neulasta biosimilar this year Sep 18 2015
U.S. SEC drops Onyx insider trading lawsuit against Dubai men Sep 16 2015
SEC drops Onyx insider trading lawsuit against Dubai men Sep 16 2015
Novartis launches first U.S. 'biosimilar' drug at 15 pct discount Sep 03 2015
AstraZeneca reboots psoriasis drug in development deal with Valeant Sep 01 2015
Amgen profit tops Street view, boosts full-year forecast Jul 30 2015
Teva to buy Allergan generic business for $40.5 bln, drops Mylan bid Jul 27 2015
Drugmaker Novartis blocked from selling Neupogen copycat until Sept. 2 Jul 21 2015
Novartis blocked from selling Neupogen copycat until September Jul 21 2015
AstraZeneca hit after psoriasis drug linked to suicide fears May 26 2015
Amgen ends partnership with AstraZeneca on psoriasis drug May 22 2015
Amgen ends collaboration with AstraZeneca on inflammation drug May 22 2015
Amgen first to win EU backing for new kind of cholesterol drug May 22 2015
Amgen cholesterol drug could get EU green light this week May 19 2015
Under pressure, FDA to hold public meeting on off-label use May 06 2015
US STOCKS-Wall St ends down as biotechs drop 4 pct; Apple up late Apr 27 2015
US STOCKS-Wall St ends down as biotechs drop 4 pct Apr 27 2015
Exclusive - Amgen's new leukemia drug to carry $178,000 price tag Dec 17 2014


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK